Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 200
  • Start Date: December 2021
EFFICACY AND SAFETY OF COMBINATION THERAPY WITH β3-ADRENOCEPTOR AGONIST (MIRABEGRON) AND α-ADRENOCEPTOR ANTAGONIST (TAMSULOSIN) FOR TREATMENT OF OVERACTIVE BLADDER IN MALE PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA.
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 990
  • Start Date: September 1, 2021
A Non Interventional Post Authorisation Multicenter Study to Evaluate the Disease Control (Benign Prostate Hyperplasia Control) Following the 6-months Combination Treatment With Dutasteride and Tamsulosin as Well as Their qualitY of Life.
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Procedure, Drug
  • Participants: 425
  • Start Date: September 2021
Prostatic Artery Embolization vs. Pharmacotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: a Multicenter Randomized Controlled Trial
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Procedure
  • Participants: 108
  • Start Date: August 1, 2021
PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 64
  • Start Date: July 1, 2021
Comparative Study Between Holmium Laser Enucleation of Prostate and Prostatic Uretheral Lift in Management of Benign Prostatic Hyperplasia
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 10
  • Start Date: May 31, 2021
SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 30
  • Start Date: May 1, 2021
Prostatic Artery Embolization (PAE) Using LC Bead LUMI for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Device
  • Participants: 30
  • Start Date: May 1, 2021
A Real World Study to Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China (Rezūm RWS Study)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug, Other
  • Participants: 262
  • Start Date: May 2021
National, Multicenter, Randomized, Double-blind, Double-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 75
  • Start Date: April 10, 2021
Prostate Artery Embolizaton: Single Center Experience
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 30
  • Start Date: April 2021
Evaluation of the Safety and Efficacy of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 100
  • Start Date: March 26, 2021
Impact of Intraoperative Instillation of Normothermal Saline on the Prevention of Intraoperative Hypothermia and Perioperative Morbidity of Prostatic Enucleation With Holmium Laser: a Prospective Randomized Controlled Study
Showing 1-12 of 98